Activating Compound | Comment | Organism | Structure |
---|---|---|---|
NADH | the cofactor acts as an allosteric activator | Homo sapiens |
Cloned (Comment) | Organism |
---|---|
expression of type 1 isozyme, wild-type and mutant enzymes, in Spodoptera frugiperda Sf9 cells via baculovirus infection | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
E126L | site-directed mutagenesis, altered kinetics compared to the wild-type enzyme | Homo sapiens |
H156Y | site-directed mutagenesis, leads to destabilization of interactions at the dimer interface and a dramatic increase in the substrate Km and inhibitor Ki values of 3beta-HSD isozyme 1 to equal those measured for 3beta-HSD isozyme 2 | Homo sapiens |
H232A | site-directed mutagenesis, altered kinetics compared to the wild-type enzyme | Homo sapiens |
K158Q | site-directed mutagenesis, results in the complete loss of dehydrogenase activity and a reduction in isomerase activity, probably due to partial destabilization of cofactor binding, in which the catalytic triad is actively involved, and associated substrate binding | Homo sapiens |
N100A | site-directed mutagenesis, altered kinetics compared to the wild-type enzyme | Homo sapiens |
N100S | site-directed mutagenesis, altered kinetics compared to the wild-type enzyme | Homo sapiens |
N323L | site-directed mutagenesis, altered kinetics compared to the wild-type enzyme | Homo sapiens |
Q105M | site-directed mutagenesis, leads to destabilization of interactions at the dimer interface and a dramatic increase in the substrate Km and inhibitor Ki values of 3beta-HSD isozyme 1 to equal those measured for 3beta-HSD isozyme 2 | Homo sapiens |
S124A | site-directed mutagenesis, results in the complete loss of dehydrogenase activity and a reduction in isomerase activity, probably due to partial destabilization of cofactor binding, in which the catalytic triad is actively involved, and associated substrate binding | Homo sapiens |
S322A | site-directed mutagenesis, altered kinetics compared to the wild-type enzyme | Homo sapiens |
Y154F | site-directed mutagenesis, results in the complete loss of dehydrogenase activity and a reduction in isomerase activity, probably due to partial destabilization of cofactor binding, in which the catalytic triad is actively involved, and associated substrate binding | Homo sapiens |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
additional information | - |
additional information | kinetics of wild-type and mutant enzymes | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | Homo sapiens | the bifunctional enzyme possesses 3beta-hydroxysteroid dehydrogenase activity, EC 1.1.1.51, and steroid DELTA-isomerase activity, the enzyme is a key steroidogenic enzyme that catalyzes the first step of the multienzyme pathway conversion of circulating dehydroepiandrosterone and pregnenolone to active steroid hormones | ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P14060 | isozyme type 1; isozyme type 1 | - |
Homo sapiens | P26439 | isozyme type 2; isozyme type 2 | - |
Purification (Comment) | Organism |
---|---|
recombinant type 1 isozyme, wild-type and mutant enzymes, from Spodoptera frugiperda Sf9 cells | Homo sapiens |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
adrenal gland | type 2 isozyme | Homo sapiens | - |
mammary gland | type 1 isozyme | Homo sapiens | - |
ovary | type 2 isozyme | Homo sapiens | - |
placenta | type 1 isozyme | Homo sapiens | - |
prostate | type 1 isozyme | Homo sapiens | - |
testis | type 2 isozyme | Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
5-Androstene-3,17-dione | - |
Homo sapiens | 4-Androstene-3,17-dione | - |
? | |
additional information | the bifunctional enzyme possesses 3beta-hydroxysteroid dehydrogenase activity, EC 1.1.1.51, and steroid DELTA-isomerase activity, the enzyme is a key steroidogenic enzyme that catalyzes the first step of the multienzyme pathway conversion of circulating dehydroepiandrosterone and pregnenolone to active steroid hormones | Homo sapiens | ? | - |
? | |
additional information | structure-function relations, analysis of three dimensional model of a ternary complex of human 3beta-HSD type 1 with an NAD+ cofactor and androstenedione product, reaction of EC 1.1.1.51, to elucidate the key substrate binding residues in the active site as well as the basis for dual function of the 3beta-HSD_1 enzyme, Asn100 and Glu126 residues are key residues that participate in the dehydrogenase and isomerization reactions, respectively, isomerase substrate binding structure, overview | Homo sapiens | ? | - |
? |
Subunits | Comment | Organism |
---|---|---|
dimer | active enzyme, interface is composed of two pairs of helices related by a 2fold symmetry axis, involved residues, overview | Homo sapiens |
Synonyms | Comment | Organism |
---|---|---|
3beta-HSD | - |
Homo sapiens |
3beta-hydroxysteroid dehydrogenase/isomerase type 1 | - |
Homo sapiens |
3beta-hydroxysteroid dehydrogenase/isomerase type 2 | - |
Homo sapiens |
More | the enzyme is a member of the short chain dehydrogenase/reductase family, cf. EC 1.1.1.51 | Homo sapiens |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
27 | - |
assay at | Homo sapiens |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.4 | - |
assay at | Homo sapiens |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
NADH | the cofactor acts as an allosteric activator | Homo sapiens |